Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy.
Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy.
复制标题
用于靶向癌症化疗光疗的仿生脂质体纳米铂
DOI:
10.1002/advs.202003679
复制
发表时间:
2021-04
期刊:
影响因子:
--
通讯作者:
Fang C
中科院分区:
文献类型:
--
作者:
Liu XL;Dong X;Yang SC;Lai X;Liu HJ;Gao Y;Feng HY;Zhu MH;Yuan Y;Lu Q;Lovell JF;Chen HZ;Fang C
Photodynamic therapy (PDT) of cancer is limited by tumor hypoxia. Platinum nanoparticles (nano‐Pt) as a catalase‐like nanoenzyme can enhance PDT through catalytic oxygen supply. However, the cytotoxic activity of nano‐Pt is not comprehensively considered in the existing methods to exert their multifunctional antitumor effects. Here, nano‐Pt are loaded into liposomes via reverse phase evaporation. The clinical photosensitizer verteporfin (VP) is loaded in the lipid bilayer to confer PDT activity. Murine macrophage cell membranes are hybridized into the liposomal membrane to confer biomimetic and targeting features. The resulting liposomal system, termed “nano‐Pt/VP@MLipo,” is investigated for chemophototherapy in vitro and in vivo in mouse tumor models. At the tumor site, oxygen produced by nano‐Pt catalyzation improves the VP‐mediated PDT, which in turn triggers the release of nano‐Pt via membrane permeabilization. The ultrasmall 3–5 nm nano‐Pt enables better penetration in tumors, which is also facilitated by the generated oxygen gas, for enhanced chemotherapy. Chemophototherapy with a single injection of nano‐Pt/VP@MLipo and light irradiation inhibits the growth of aggressive 4T1 tumors and their lung metastasis, and prolongs animal survival without overt toxicity. The biomimetic liposomal nano‐Pt (nano‐Pt/VP@MLipo) targets the tumor sites, where oxygen produced by nano‐Pt catalyzation enhances the verteporfin (VP)‐mediated photodynamic therapy (PDT). PDT in turn permeabilizes the liposome membrane for efficient nano‐Pt release. These ultrasmall particles (3–5 nm) achieve penetration in deeper tumor tissue, which is also facilitated by the generated oxygen gas, for enhanced chemotherapy.
登录
查看更多内容
DOI:
10.1002/advs.202003679
发表时间:
2021-04
期刊:
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
影响因子:
--
作者:
Liu XL;Dong X;Yang SC;Lai X;Liu HJ;Gao Y;Feng HY;Zhu MH;Yuan Y;Lu Q;Lovell JF;Chen HZ;Fang C
通讯作者:
Fang C
影响因子:
14
作者:
Luo D;Carter KA;Razi A;Geng J;Shao S;Giraldo D;Sunar U;Ortega J;Lovell JF
通讯作者:
Lovell JF
影响因子:
4.7
作者:
Ai, Xiangzhao;Hu, Ming;Xing, Bengang
通讯作者:
Xing, Bengang
影响因子:
--
作者:
Ivascu, Andrea;Kubbies, Manfred
通讯作者:
Kubbies, Manfred
影响因子:
10.8
作者:
Chen, Zhong-Jian;Yang, Si-Cong;Fang, Chao
通讯作者:
Fang, Chao